ABCB11 accumulated in immature tertiary lymphoid structures participates in xenobiotic metabolic process and predicts resistance to PD-1/PD-L1 inhibitors in head and neck squamous cell carcinoma

[1]  X. Ren,et al.  CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer , 2022, Cell Death & Disease.

[2]  Cong-Zhao Zhou,et al.  Structures of human bile acid exporter ABCB11 reveal a transport mechanism facilitated by two tandem substrate-binding pockets , 2022, Cell Research.

[3]  P. Cooper,et al.  Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer , 2021, Scientific Reports.

[4]  Jun Liu,et al.  Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies , 2021, Frontiers in Immunology.

[5]  J. Rueff,et al.  The Central Role of Cytochrome P450 in Xenobiotic Metabolism—A Brief Review on a Fascinating Enzyme Family , 2021, Journal of xenobiotics.

[6]  Yi Zhao,et al.  Imbalance of TGF-β1/BMP-7 Pathways Induced by M2-polarized Macrophages Promotes Hepatocellular Carcinoma Aggressiveness. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Lina Wen,et al.  Identification and validation of xenobiotic metabolism-associated prognostic signature based on five genes to evaluate immune microenvironment in colon cancer. , 2021, Journal of gastrointestinal oncology.

[8]  A. Acco,et al.  Involvement of cytochrome P450 enzymes in inflammation and cancer: a review , 2020, Cancer Chemotherapy and Pharmacology.

[9]  J. Pawlotsky,et al.  Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules , 2020, Clinical Cancer Research.

[10]  Cong-Zhao Zhou,et al.  Cryo-EM structure of human bile salts exporter ABCB11 , 2020, Cell Research.

[11]  J. Califano,et al.  B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade , 2020, Clinical Cancer Research.

[12]  K. Akashi,et al.  Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer , 2020, Oncoimmunology.

[13]  Jeffrey E. Lee,et al.  B cells and tertiary lymphoid structures promote immunotherapy response , 2020, Nature.

[14]  J. Wargo,et al.  B cells are associated with survival and immunotherapy response in sarcoma , 2020, Nature.

[15]  A. Guo,et al.  ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy , 2019, bioRxiv.

[16]  Reem Saleh,et al.  Treg-mediated acquired resistance to immune checkpoint inhibitors. , 2019, Cancer letters.

[17]  H. Morgenstern,et al.  Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach. , 2019, Oral oncology.

[18]  G. Descamps,et al.  Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma , 2019, Cancers.

[19]  A. Luciani,et al.  Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. , 2019, Journal of hepatology.

[20]  E. Bezirtzoglou,et al.  The Role of Cytochromes P450 in Infection , 2018, Front. Immunol..

[21]  R. Stupp,et al.  Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer , 2017, Oncoimmunology.

[22]  L. Pignataro,et al.  T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma , 2017, Oncoimmunology.

[23]  J. Radford.  Nivolumab for recurrent squamous-cell carcinoma of the head and neck , 2016, BDJ.

[24]  K. Harrington,et al.  Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. , 2016, The New England journal of medicine.

[25]  Á. Telbisz,et al.  Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function , 2016, Expert opinion on therapeutic targets.

[26]  K. Rajewsky,et al.  Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma , 2015, Nature Immunology.

[27]  Risto O. Juvonen,et al.  Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes , 2015, Front. Pharmacol..

[28]  C. Sautès-Fridman,et al.  Tertiary lymphoid structures in cancer and beyond. , 2014, Trends in immunology.

[29]  M. Karamouzis,et al.  Head and neck cancer , 2008, The Lancet.

[30]  P. Harrison,et al.  Profiling early head and neck cancer , 2005, Nature Reviews Cancer.

[31]  T. Takahara,et al.  Functional B‐cell response in intrahepatic lymphoid follicles in chronic hepatitis C , 1999, Hepatology.

[32]  Holger Moch,et al.  Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma. , 2018, Cancer research.